Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Pavlakis

Showing results (191-200 of 294) with videos related to

Pageof 30
Sort By:
Vaccine|January 19, 2011
Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopesLiguo Niu, James M Termini, Saravana K Kanagavelu, et al.
Glycoconjugate Journal|November 14, 2015
Recombinant human heterodimeric IL-15 complex displays extensive and reproducible N- and O-linked glycosylationM Thaysen-Andersen, E Chertova, C Bergamaschi, et al.
DNA and Cell Biology|November 6, 2007
Efficient systemic expression of bioactive IL-15 in mice upon delivery of optimized DNA expression plasmidsRashmi Jalah, Margherita Rosati, Viraj Kulkarni, et al.
Asia-Pacific Journal of Clinical Oncology|August 11, 2017
Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian contextM Itchins, P L Chia, S A Hayes, et al.
Journal of Medical Primatology|May 10, 2014
DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaquesViraj Kulkarni, Margherita Rosati, Rashmi Jalah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2010
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive careT R Asmis, E Powell, C S Karapetis, et al.
Journal of Virology|December 12, 2001
Rev-independent simian immunodeficiency virus strains are nonpathogenic in neonatal macaquesAgneta S von Gegerfelt, Vladimir Liska, Pei-Lin Li, et al.
Frontiers in Immunology|December 13, 2021
Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 InfectionMargherita Rosati, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al.
Vaccine|August 19, 2003
Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinantsJun Zhao, Yuanmei Lou, Joel Pinczewski, et al.
Journal of Virology|July 15, 2003
Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimenJun Zhao, Joel Pinczewski, Victor R Gómez-Román, et al.
Pageof 30

Showing results (191-200 of 294) with videos related to

Sort By:
Pageof 30
Vaccine|January 19, 2011
Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopesLiguo Niu, James M Termini, Saravana K Kanagavelu, et al.
Glycoconjugate Journal|November 14, 2015
Recombinant human heterodimeric IL-15 complex displays extensive and reproducible N- and O-linked glycosylationM Thaysen-Andersen, E Chertova, C Bergamaschi, et al.
DNA and Cell Biology|November 6, 2007
Efficient systemic expression of bioactive IL-15 in mice upon delivery of optimized DNA expression plasmidsRashmi Jalah, Margherita Rosati, Viraj Kulkarni, et al.
Asia-Pacific Journal of Clinical Oncology|August 11, 2017
Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian contextM Itchins, P L Chia, S A Hayes, et al.
Journal of Medical Primatology|May 10, 2014
DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaquesViraj Kulkarni, Margherita Rosati, Rashmi Jalah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2010
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive careT R Asmis, E Powell, C S Karapetis, et al.
Journal of Virology|December 12, 2001
Rev-independent simian immunodeficiency virus strains are nonpathogenic in neonatal macaquesAgneta S von Gegerfelt, Vladimir Liska, Pei-Lin Li, et al.
Frontiers in Immunology|December 13, 2021
Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 InfectionMargherita Rosati, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al.
Vaccine|August 19, 2003
Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinantsJun Zhao, Yuanmei Lou, Joel Pinczewski, et al.
Journal of Virology|July 15, 2003
Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimenJun Zhao, Joel Pinczewski, Victor R Gómez-Román, et al.
Pageof 30